000 | 02857cam a2200349 a 4500 | ||
---|---|---|---|
003 | EG-GiCUC | ||
005 | 20250223032553.0 | ||
008 | 200906s2020 ua dh f m 000 0 eng d | ||
040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
041 | 0 | _aeng | |
049 | _aDeposite | ||
097 | _aPh.D | ||
099 | _aCai01.11.10.Ph.D.2020.Yo.A | ||
100 | 0 | _aYousra Abdulsalam Muhammad Hasan Azzazi | |
245 | 1 | 0 |
_aAssessment of atherosclerotic cardiovascular risk and oxidative stress in vitiligo : _bA case control study / _cYousra Abdulsalam Muhammad Hasan Azzazi ; Supervised Wedad Zoheir Mostafa , Khadiga Sayed Sayed , Nanis Abdelaleem Ragab |
246 | 1 | 5 |
_aتقييم مخاطر إصابة القلب و الأوعية الدموية بتصلب الشرايين المرتبط بالإجهاد التأكسدى فى مرضى البهاق : _bدراسة للحالات و الشواهد |
260 |
_aCairo : _bYousra Abdulsalam Muhammad Hasan Azzazi , _c2020 |
||
300 |
_a134 , (12) P. : _bcharts , facsimiles ; _c25cm |
||
502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Dermatology and Venerology | ||
520 | _aBackground:Vitiligo is a relatively common skin depigmenting disorder, of multifactorial etiology including genetic, immunologicaland oxidant-antioxidant imbalance.Nonsegmental vitiligo, the commonest form of vitiligo, is now postulated to be a systemic disease, rather than a mere dermatological disorder, having a strong association with several systemic and metabolic disturbances, including insulin resistance, dyslipidemia, atherosclerotic cardiovascular disease (CVD) and metabolic syndrome. However, contradicting data were also published, denoting that vitiligo patients tend to have lower cardiovascular risk than controls. Methods:In this hospital based, cross sectional, case-control study, 50 patients with non-segmental vitiligo and 50 age and sex matched controls were included. All study subjects were selected from non-smoking subjects, free from diabetes mellitus, hypertension and obesity. Serum lipid profile (including LDL-C, HDL-C, total cholesteroland triglycerides),in addition to serum oxidative stress biomarkers (hydrogen peroxide, malondialdehyde, nitric oxide and total antioxidant capacity) were measured. Carotid duplexwas performedwithestimation of common carotid intima media thickness (CCIMT) and assessment for atherosclerotic plaque presence and measurements | ||
530 | _aIssued also as CD | ||
653 | 4 | _aAtherosclerosis | |
653 | 4 | _aCarotid intima media thickness | |
653 | 4 | _aLipid profile | |
700 | 0 |
_aKhadiga Sayed Sayed , _eSupervisor |
|
700 | 0 |
_aNanis Abdelaleem Ragab , _eSupervisor |
|
700 | 0 |
_aWedad Zoheir Mostafa , _eSupervisor |
|
856 | _uhttp://172.23.153.220/th.pdf | ||
905 |
_aNazla _eRevisor |
||
905 |
_aShimaa _eCataloger |
||
942 |
_2ddc _cTH |
||
999 |
_c77593 _d77593 |